Vascular Embolization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Vascular Embolization Market Analysis

The Global Vascular Embolization Market size is estimated at USD 1.94 billion in 2024, and is expected to reach USD 2.75 billion by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).

The outbreak of COVID-19 impacted the vascular embolization market, as hospitals and healthcare services for non-COVID indications were significantly reduced due to social distancing measures enforced globally. However, many research studies have proven that vascular embolization techniques are safe during the COVID-19 pandemic if performed with utmost care and precautions. According to a research study titled "Bronchial Artery Embolization Performed in COVID-19 Patients: Tolerance and Outcomes", published in 2020, the results demonstrated that management of severe hemoptysis (SH) in COVID-19 patients with bronchial artery embolization (BAE) was feasible and efficient, and concerning the safety guidelines, it is of utmost importance to protect the interventional radiology (IR) staff. Thus, owing to the aforementioned factors, the studied market is expected to be impacted during the COVID-19 pandemic.

The increasing prevalence of vascular diseases, technological advancements in embolization products and procedures, increasing research and development activities, and growing demand for minimally invasive procedures are the key driving factors in the global vascular embolization market. According to the 2020 updates of the World Health Organization, ischemic heart disease is responsible for 16% of the world's total deaths annually. Additionally, according to the World Health Organization, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. In addition, according to the article published in Cureus Journal of Medical Science in July 2020, ischemic heart disease (IHD) is a leading cause of death worldwide. Ischemic heart disease affects around 126 million individuals (1,655 per 100,000) globally, which is approximately 1.72% of the world's population. The global prevalence of ischemic heart disease is expected to exceed 1,845 per 100,000 by the year 2030.owing to cardiovascular diseases that include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other heart conditions. It is one of the leading causes of death worldwide.

Moreover, compared to conventional surgeries, the several advantages of minimally invasive surgeries, such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time, are encouraging an increasing number of patients to opt for minimally invasive balloon angioplasty surgeries. As per the data reported by the American College of Cardiology, in 2020, approximately 1.2 million angioplasties were performed in a year in the United States. Moreover, the high accessibility and affordability of hospitals, as compared to the specialty clinics, are expected to attract a large patient population.

Also, a few of the key players are developing and launching novel products and technologies to compete with the existing products, while others are acquiring and partnering with the other companies trending in the market. For instance, in February 2020, EmboCube and Torpedo devices of Merit Medical Systems Inc. were FDA indicated for the embolization of blood vessels to occlude blood flow, thus aiding in the control of bleeding and hemorrhaging in the peripheral vasculature. Thus, owing to the aforementioned factors, the studied segment is expected to grow over the forecast period. However, the high cost associated with the procedures, stringent regulations, and complications associated with these procedures are expected to hinder the growth of the market studied.

Vascular Embolization Market Trends

This section covers the major market trends shaping the Vascular Embolization Market according to our research experts:

The Non-coiling Devices Segment is Expected to Hold a Major Market Share in the Vascular Embolization Market over the Forecast Period

Vascular Embolization Industry Segmentation

As per the scope of the report, vascular embolization is a procedure in which an embolic agent is injected into blood vessels to close them and stop the blood flow to a targeted area. The vascular embolization market is segmented by embolization technique, application, and geography. By embolization technique, the market is segmented into coiling devices and non-coiling devices. By application, the market is segmented into peripheral vascular disease, oncology, neurology, urology, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.